SEC Filing Summary: Synaptogenix, Inc. (SNPX)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Synaptogenix, Inc. on October 1, 2021, covering events occurring on September 30, 2021. The registrant is a Delaware corporation listed on The Nasdaq Stock Market LLC under the symbol SNPX and is classified as an emerging growth company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
On September 30, 2021, George Perry resigned from his position as a member of the Board of Directors and all associated committees. The resignation was voluntary and not the result of any disagreement with the Company's operations, policies, or practices. Following his resignation, Mr. Perry will continue to serve the Company in an advisory capacity as Chairman of the Scientific Advisory Board.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, risks, contingencies, or unusual items. The document is limited to the disclosure of the director's departure and subsequent advisory role.
Key Facts for Investor Verification
- George Perry resigned from the Board of Directors effective September 30, 2021.
- The resignation was voluntary with no stated disagreement with company management.
- Mr. Perry remains with the company as Chairman of the Scientific Advisory Board.
- No financial data or operational metrics are disclosed in this specific filing.